Bristol-Myers Squibb reports progress from African health programme
20 July 2010 00:00 in Pharmaceutical Company Product News
Bristol-Myers Squibb has highlighted the achievements made in an ongoing scheme to support healthcare initiatives in underprivileged areas in Africa.
Speaking at the XVIII International AIDS Conference in Vienna, the pharmaceutical company reported on the progress of Secure the Future, an anti-HIV and tuberculosis initiative being conducted by its charitable body the Bristol-Myers Squibb Foundation.
The programme is now in its 11th year and is sponsoring a number of community projects across the region, including treatment and screening initiatives and the development of pharmacist-based HIV/AIDS services in southern Africa.
John Damonti, president of Bristol-Myers Squibb Foundation, said that its projects are helping to empower local communities to be able to cope with the impact of the deadly infections.
He added that the programme has now generated "substantial experience in delivering innovative community-based interventions to support the HIV-positive population".
Earlier this month, Bristol-Myers Squibb was granted permission to launch a new paediatric indication of its HIV drug Reyataz in Europe.
Other news stories from 20/07/2010
Read more in the Zenopa News Archive
How this news is generated
Story collated for Zenopa by the Adfero News Agency